drugset / Trial / NCT02751606
Nano MRI on 7 Tesla in Rectal and Breast Cancer
NaSingle-groupOpen-labelDiagnostic
Summary
This study evaluates the diagnostic accuracy of an USPIO contrast agent (ferumoxtran-10) in combination with 7 Tesla MRI to detect lymph node metastases in rectal and breast cancer.
Timeline
- Start
- 2015-06
- Primary completion
- 2019-06
- Completion
- 2019-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ferumoxtran-10 | Diagnostic / imaging agent | — | Intravenous |